ArticleCellular oncology (Dordrecht, Netherlands)2021
CHRNA5 belongs to the secondary estrogen signaling network exhibiting prognostic significance in breast cancer.
Huma Shehwana et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
10 papers cite it
this papercites it